GlassScriptPhysician profile
Justin T Allen
NPI 1871154229
$2,705.31
in general payments reported to CMS, 2019-2025
25 companies · $854 in 2025
The $854 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $198 · 2023: $426 · 2024: $923 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.52 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $405.76 | 2021-2025 | Artix Mt, Gamma |
| Silk Road Medical, INC. | $344.32 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $317.64 | 2021-2025 | Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Neuroprotection System, General - Pain Management |
| Medtronic, INC. | $271.44 | 2024-2025 | Valiant Captivia, Heli-Fx Endoanchor System |
| Endologix LLC | $142.52 | 2025 | Torus Stent Graft System, Endocross Device |
| Medical Device Business Services, INC. | $137.01 | 2023 | Stratafix |
| Pacira Pharmaceuticals Incorporated | $121.69 | 2021 | |
| Ethicon US, LLC | $109.90 | 2021-2023 | Monocryl, Surgicel Nu-Knit, Vistaseal |
| Smith+Nephew, INC. | $102.28 | 2021-2025 | Renasys Touch, Collagenase Santyl, Pico 14 |
| Gilead Sciences, INC. | $96.16 | 2024 | Epclusa |
| Becton, Dickinson and Company | $81.53 | 2023-2024 | Venclose Maven Catheter, Denali Vena Cava Filter |
| Solventum Corporation | $70.06 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Contego Medical, INC | $68.63 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $66.95 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $49.79 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $46.93 | 2023-2024 | Celleraterx |
| Kerecis Limited | $46.62 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Convatec INC. | $42.54 | 2024 | |
| Bard Peripheral Vascular, INC. | $41.47 | 2025 | |
| Edwards Lifesciences Corporation | $35.61 | 2024 | |
| Surmodics, INC. | $31.65 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Globus Medical, INC. | $25.42 | 2023 | Tibial Nail |
| Acera Surgical, INC. | $25.16 | 2025 | Restrata Wound Matrix |
| Alon Medical Technology | $15.76 | 2024 | |
| Nexxt Spine LLC | $8.47 | 2023 | Nexxt Matrixx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.